Zacks Investment Research | Mar 11, 2020 09:33PM ET
OrthoPediatrics Corp. (NASDAQ:KIDS) announced the limited launch or beta release of its Large Fragment Cannulated Screw System in the United States. Notably, this is the 34th surgical system from the company’s portfolio, which is designed to address the needs of the pediatric population.
Per OrthoPediatrics, its development team collaborated with four pediatric orthopedic surgeons from prominent institutions worldwide on the design of the screw implants and instruments. The medical fraternity believes that the innovative design of the screw system will enable them to overcome challenges in the operating room.
With the limited domestic launch, OrthoPediatrics aims to strengthen its pediatric orthopedic business globally.
Significance of the Launch
The latest screw system, which is available in two variations, will be utilized to address trauma procedures as well as treating children with a condition known as Slipped Capital Femoral Epiphysis (“SCFE”). The company is looking forward to an expanded market adoption from physicians as the screw system will be able to treat a wide array of conditions of bones and large bone fragments.
Industry Prospects
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.